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Summary
• Benzylamine is able to enter the yeast cells with an intact membrane,
indicating that it has the potential to affect cell growth and
metabolism (Figures 3 and 4).
• The yeast mutants have different growth patterns at different
concentrations of benzylamine. Some concentrations appear to be
growth inhibitory while others promote growth.
• Hydrogen peroxide and benzylamine limited cell growth drastically
at concentrations greater than 2mM. This indicates a
potential interaction between oxidative stress pathways and
benzylamine.
• Δyap1, Δtsa, Δaif1, and Δzwf1 showed differences in growth and are
involved in oxidative stress response
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Oxidative stress occurs when there is an imbalance of reactive oxygen
species and antioxidants. The brain is especially vulnerable to the effects
of ROS because of its high oxygen demand. Previous studies have
demonstrated that oxidative stress plays a central role in common
neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s
disease. Furthermore, ROS have been found to trigger programmed cell
death in cancer cells. Our lab aims to investigate the oxidative stress
response in Saccharomyces cerevisiae by studying its growth at different
concentrations of a compound called benzylamine, which is thought to
have possible anticancer effects. To identify the different biological
pathways being affected by the compound, we began by testing different
concentrations of the compound with DMSO on yeast mutants. Each
mutant had a different non-essential gene deleted. We found that the yeast
has different growth compared to the control at both the 30nM and
300nM concentrations while still not being completely wiped out. After
evaluating the growth patterns of twenty-six different yeast mutants in
comparison to untreated and wild type cells, we identified four proteins to
focus on that are involved in similar biological pathways: Δzwf1, Δyap1,
Δaif1, and Δtsa1.

Results and Discussion

30nM
3nM

0.1

0
0

0.5

1

1.5

2

2.5

3

3.5

4

4.5

5

Time (Hours)

Future Work
Fig 3. shows the change in optical density levels of wild type
yeast cells when exposed to different concentrations of
benzylamine

Fig 6. Shows the serial dilutions of the different yeast mutations at
a low concentration of DMSO
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1.Further observation into specific cellular pathways impacted by
benzylamine
2.Protein isolations
3.Western blots to determine the effect of benzylamine on the
expression of proteins involved in the response to oxidative stress
4.Similar co-treatment tests in breast cancer cells to determine
minimum growth inhibitory concentration when combined with
oxidative stress promoter
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Fig 1. examples of both endogenous and exogenous sources of
oxidative stress

Fig 4. shows the change in optical density of Δerg6 mutated
yeast cells when exposed to different concentrations of
benzylamine

Methods

Table 1. Quantifies the cell growth from the spotted plates. A plus sign indicates
that the growth has increased compared to the control, a minus indicates a
decrease, and a 0 indicates no change compared to the control. Gene deletions
outlined in red were chosen to study further in the next step of looking at the effect
of benzylamine on protein expression
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Fig 5. Shows the serial dilutions of the different yeast mutations at a
high concentration of DMSO. Each mutation listed on the left are
gene deletions. The 300nM concentration was used in the next step to
see how benzylamine affects protein expression.

Fig 2. Flowchart showing the methodological steps leading up to
protein isolation
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Fig 7. Shows serial dilutions of the combined effect of 30nM benzylamine concentration
and hydrogen peroxide on cells
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